Mydecine Innovation

About:

Mydecine Innovation Group is an innovative Cannabidiol ("CBD") lifestyle Company.

Website: https://mydecineinc.com/

Twitter/X: mydecineig

Description:

Mydecine is a biotechnology company developing first- and second-generation novel compounds to treat mental health and addiction disorders through world-class technology and drug development infrastructure. The company's medical and scientific advisory board is progressing a robust research and development (R&D) pipeline of psychedelic-derived therapeutics, novel compounds, therapies, and controlled drug delivery systems.

Total Funding Amount:

$2M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Denver, Colorado, United States

Founded Date:

2020-01-01

Contact Email:

info(AT)nlbrandsinc.com

Founders:

Damon Michaels

Number of Employees:

11-50

Last Funding Date:

2020-06-01

IPO Status:

Public

Industries:

© 2025 bioDAO.ai